Global X Cloud Computing ETF (NASDAQ: CLOU)

에 대한 최신 뉴스 Global X Cloud Computing ETF (NASDAQ:CLOU)

Technology

Communication Services

Real Estate

Consumer Cyclical

Healthcare

Other

The Fund invests at least 80 percent of its total assets in the securities of the Indxx Global Cloud Computing Index (Underlying Index) and in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) based on the securities in the Underlying Index. The Fund's 80 percent investment policy is non-fundamental and requires 60 days prior written notice to shareholders before it can be changed. The Fund may lend securities representing up to one-third of the value of the Funds total assets (including the value of the collateral received).

Wix.com Ltd

Sps Commerce Inc

Box Inc

Digital Realty Trust Inc.

Procore Technologies Pp

Zscaler Inc

Dropbox Inc. Class A

Paycom Software Inc.

Akamai Technologies Inc.

C3 Ai Inc A

Global X Cloud Computing ETF

Equities

News

Markets

Tech

General

ARKW

CLOU

GOOG

GOOGL

IONQ

MSFT

NVDA

QBTS

QTUM

QUBT

RGTI

WCLD

양자 컴퓨팅은 인공지능(AI)이 디지털 환경을 혁신적으로 변화시킨 것과 마찬가지로 산업을 혁신할 게임 체인저 기술로 떠오르고 있다. 2025년을 향해 나아가면서 전문가들은 양자 컴퓨팅이 기술의 다음 주요 경계가 되어 엄청난 계산 능력을 열어주고 암호화, 약물 발견 및 최적화와 같은 분야에서의 혁신을 이끌 것이라고 예측하고 있다.

양자 컴퓨팅: 새로운 AI? 2025년에 빠르게 확장되는 시장 및 상위 주식 살펴보기

Cloud - United States dollar

Cloud DX Inc

Cloud Nine Web3 Technologies Inc

CLOUD3 VENTURES INC NEW by CLOUD3 VENTURES INC

Cloud3 Ventures Inc

Cloud3 Ventures Inc Ordinary Shares (Sub Voting)

CloudMD Software & Services Inc Ordinary Shares

Cloudastructure Inc

CLOUDBREAK DISCOVERY PLC by Cloudbreak Discovery PLC

Cloudbreak Discovery PLC

Cloudflare Inc

Cloudweb Inc

Clough Global Dividend and Income Fund Common Shares of beneficial interest

Clough Global Dividend and Income Fund

Clough Global Equity Fund Clough Global Equity Fund Common Shares of Beneficial Interest

Clough Global Equity Fund

Clough Global Opportunities Fund Common Stock

Clough Global Opportunities Fund

Clough Hedged Equity ETF

Clough Select Equity ETF

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on CEVA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEVA#NASDAQ">CEVA</a>) in the last three months.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have set 12-month price targets for CEVA, revealing an average target of $34.5, a high estimate of $40.00, and a low estimate of $28.00. Witnessing a positive shift, the current average has risen by 23.21% from the previous average price target of $28.00.
<img src="https://www.benzinga.com/files/images/story/2024/1734958831_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
A comprehensive examination of how financial experts perceive CEVA is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Gus Richard</td>
<td>Northland Capital Markets</td>
<td>Raises</td>
<td>Outperform</td>
<td>$35.00</td>
<td>$31.00</td>
</tr>
<tr>
<td>Kevin Cassidy</td>
<td>Rosenblatt</td>
<td>Raises</td>
<td>Buy</td>
<td>$35.00</td>
<td>$28.00</td>
</tr>
<tr>
<td>Suji Desilva</td>
<td>Roth MKM</td>
<td>Raises</td>
<td>Buy</td>
<td>$40.00</td>
<td>$25.00</td>
</tr>
<tr>
<td>Kevin Cassidy</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$28.00</td>
<td>$28.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to CEVA. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of CEVA compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of CEVA's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of CEVA's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/CEVA/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on CEVA analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind CEVA</h2>
CEVA Inc is a licensor of signal-processing intellectual property. Through partnerships with semiconductor companies and original equipment manufacturers globally, the company helps produce devices for a range of end markets. OEMs and semiconductor companies choose to sell products with CEVA equipment to wireless, consumer, automotive, and Internet of Things companies. Revenue is derived primarily from licensing fees and related revenue, and royalties generated from the shipments of products utilizing its intellectual properties. CEVA also engages in the training and sale of development systems.
<h3>CEVA: Financial Performance Dissected</h3>
Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.
Revenue Growth: CEVA displayed positive results in 3 months. As of 30 September, 2024, the company achieved a solid revenue growth rate of approximately 13.02%. This indicates a notable increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Information Technology sector.
Net Margin: CEVA's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of -4.82%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): CEVA's ROE excels beyond industry benchmarks, reaching -0.5%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): CEVA's ROA excels beyond industry benchmarks, reaching -0.43%. This signifies efficient management of assets and strong financial health.
Debt Management: CEVA's debt-to-equity ratio is below the industry average at 0.02, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: Simplified</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

CEVA

Deep Dive Into CEVA Stock: Analyst Perspectives (4 Ratings)

Cigna's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CI#NYSE">CI</a>) short percent of float has fallen 10.85% since its last report. The company recently reported that it has 3.19 million shares sold short, which is 1.15% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.05 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Cigna Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734958826_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Cigna has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Cigna's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Cigna's peer group average for short interest as a percentage of float is 8.21%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Looking Into Cigna's Recent Short Interest

Discover Financial Restates Diluted EPS For Quarter Ended Sept 30, 2024 To $3.32

Casella Waste Sys's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CWST#NYSE">CWST</a>) short percent of float has risen 7.5% since its last report. The company recently reported that it has 2.13 million shares sold short, which is 3.44% of all regular shares that are available for trading. Based on its trading volume, it would take traders 7.74 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Casella Waste Sys Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734958821_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Casella Waste Sys has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Casella Waste Sys's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Casella Waste Sys's peer group average for short interest as a percentage of float is 3.18%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

CWST

How Is The Market Feeling About Casella Waste Sys?

Blackstone's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BX#NYSE">BX</a>) short percent of float has fallen 3.0% since its last report. The company recently reported that it has 16.43 million shares sold short, which is 2.26% of all regular shares that are available for trading. Based on its trading volume, it would take traders 4.9 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Blackstone Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1734958815_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Blackstone has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Blackstone's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Blackstone's peer group average for short interest as a percentage of float is 3.17%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into Blackstone's Recent Short Interest

BMO Capital analyst Jeffrey Silber maintains FactSet Research Systems (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDS#NYSE">FDS</a>) with a Market Perform and lowers the price target from $521 to $518.

Price Target

BMO Capital Maintains Market Perform on FactSet Research Systems, Lowers Price Target to $518

BMO Capital analyst Evan David Seigerman maintains Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) with a Outperform and lowers the price target from $156 to $105.

BMO Capital Maintains Outperform on Novo Nordisk, Lowers Price Target to $105

AILEW

Trading Halt: Halted at 7:56:15 a.m. ET - Trading Halt: Halt News Pending

AILE

Citigroup analyst William Katz maintains BlackRock (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) with a Buy and raises the price target from $1150 to $1200.

Citigroup Maintains Buy on BlackRock, Raises Price Target to $1200

BTIG analyst Thomas Catherwood downgrades Innovative Ind Props (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) from Buy to Neutral.

Downgrades

IIPR

BTIG Downgrades Innovative Ind Props to Neutral

Northland Capital Markets analyst Mike Grondahl maintains Encore Capital Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ECPG#NASDAQ">ECPG</a>) with a Outperform and raises the price target from $58 to $66.

ECPG

Northland Capital Markets Maintains Outperform on Encore Capital Gr, Raises Price Target to $66

Northland Capital Markets analyst Gus Richard maintains CEVA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CEVA#NASDAQ">CEVA</a>) with a Outperform and raises the price target from $31 to $35.

Northland Capital Markets Maintains Outperform on CEVA, Raises Price Target to $35

At the beginning of 2024, Benzinga noted <a target="_blank" href="https://www.benzinga.com/markets/commodities/24/01/36452207/4-mining-stocks-to-watch-in-2024-aura-oceanagold-alphamin-b2gold" rel="noreferrer noopener">four mining stocks</a> to follow while evaluating tailwinds like green tech demand and persistent inflation. Although gold, as a benchmark, has had one of the best years on record, outperforming even the surging equities market, miners delivered mixed results.
<h3 class="wp-block-heading">Aura Minerals</h3>
Aura Minerals (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/ORAAF#OTCQX">ORAAF</a>) is a gold and copper miner focused on Central and South America, with primary operations in Brazil, Mexico, and Honduras. During 2024, the company made notable asset acquisitions, obtaining rights to explore Pé Quente and Pezão projects to boost its reserves. The company also acquired Bluestone Resources, a junior miner with a promising high-grade gold deposit in Guatemala.
The company recently reported its second-best quarter by adjusted EBITDA and decreased all-in-sustained costs to $1,292/ounce. The stock was a strong performer, rising 85% year-to-date.
<h3 class="wp-block-heading">OceanaGold</h3>
OceanaGold (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OCANF#OTC">OCANF</a>) is a mid-tier gold and copper producer with production in New Zealand, the Philippines, and the United States. It originally started as Macraes Mining Company, named after the foundation asset in New Zealand, which produced over 5 million ounces of gold since 1990. During 2024, the company focused on advancing the Didipio gold and copper project in the Philippines and providing initial mineral reserves for the proposed Wharekirauponga gold mine in New Zealand of 1.2 million ounces, with a projected IRR of 24% at a gold price of $2,400 per ounce.
Per the latest earnings, the company increased quarterly production from all sites, achieving a net profit of $61 million and boosting cash reserves. Since the beginning of the year, the stock rose 60.4%.
<h3 class="wp-block-heading">Alphamin Resources</h3>
Alphamin Resources (OTC:<a class="ticker" href="https://www.benzinga.com/stock/AFMJF#OTC">AFMJF</a>) is a miner focused on producing tin, a critical mineral used for metal coating and the production of superconducting magnets. The company's principal project is the Bisie mine, the world's highest-grade tin mine.
In 2024, Alphamin achieved record quarterly tin production, in excess of 4,000 tons, staying on track to its production target of 20,000 tons annually. For the next growth step, the firm plans to connect its mining sites to have one producing unit feeding two processing facilities. Management estimates they could scale up output to 25,000 tons. The last drill campaign added 175,000 tons of reserves. Alphamin's stock returned 21.1% year-to-date.
<h3 class="wp-block-heading">B2Gold</h3>
B2Gold (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/BTG#AMEX">BTG</a>) is a mid-tier mining company operating mines in emerging markets and exploration activities in more stable jurisdictions like Canada and Finland. The company's principal asset is the Fekola mine in Mali, with an annual production exceeding 500,000 ounces. Its other operating assets include Masabe in the Philippines and Otjikoto in Namibia.B2Gold had a volatile year, as <a target="_blank" href="https://www.benzinga.com/news/guidance/24/12/42516175/barrick-warns-about-destabilization-in-mali-could-halt-one-of-its-largest-mines" rel="noreferrer noopener">escalating instability in Mali</a> resulted in the off-site deaths of multiple employees and an increasingly complex situation with the ruling military junta. Furthermore, the higher-than-anticipated capital costs for a project in northern Canada have weighed on financials. Owing to these setbacks, B2Gold has lost 14.4% year-to-date.
As of December 20, VanEck Junior Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDXJ#NYSE">GDXJ</a>) returned 16.67% year-to-date.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/24/12/42628973/billionaire-investor-bullish-on-gold-miners-including-this-penny-stock" target="_blank" rel="noreferrer noopener">Billionaire John Paulson Bullish On Gold Miners, Including This Penny Stock</a></li>
</ul>
Image via Shutterstock

Commodities

AFMJF

GDXJ

OCANF

ORAAF

Reviewing Benzinga's Mining Watchlist For 2024

COSCIENS Biopharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCI#NASDAQ">CSCI</a>) (TSX:<a class="ticker" href="https://www.benzinga.com/stock/CSCI#TSX">CSCI</a>) ("COSCIENS" or the "Company"), a specialty biopharmaceutical company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and pharmaceutical products, today provided a corporate update and reiterated its pipeline prioritization.
"Over the course of the last several months following the merger, we have taken strategic and deliberate steps to evaluate and prioritize our combined pipeline of products and programs. Through this effort, we have thoroughly evaluated the potential of our assets and prioritized the areas that we believe are high-value opportunities, and we plan to move forward focusing our resources on advancing a pipeline of natural-based products leveraging our core technologies. We believe that this focus, spanning cosmeceuticals, nutraceuticals and pharmaceuticals, positions us with near and long-term life science growth drivers and the potential to become a global leader in natural-based products for health and wellness," stated <a href="https://www.globenewswire.com/Tracker?data=XGEB5e3QJGs0rAZIEn9x3enzUNiQFyPKt0kKPnr1xjTKfNlMsAdacP2YgVUlHhRD5gSQwGVhUPozg71YRlEgMHW38CEK1DDrHxEAYh0ecfkZ-ZDfyBuCxSyjQEpSMY-zoQ4WmYnYksKrGXJWHDk_2w==">Gilles Gagnon, M.Sc., MBA, President and CEO</a> of COSCIENS. "In addition, we have continued to make progress driving revenues and growing our active ingredients base business. We are looking to kick off 2025 with a clear line of sight towards execution of our business plan and believe we are well-positioned for a transformational year."
Development Projects Update
Pharmaceuticals:
<ul>
<li>Avenanthramides Tablets (Avs) in Development as an Anti-Inflammatory: The Phase 1-2a clinical trial being conducted at the Montreal Heart Institute has fully completed the Phase 1 part of the study with 72 subjects tested. No significant side effects have been observed from ascending doses ranging from 30 mg to 960 mg. The Company expects the Phase 2a efficacy study will be initiated in Q1 2025, with expected completion in Q3 2025. &nbsp;</li>
</ul>
Cosmeceuticals:
<ul>
<li>Enriched Oat Flour with High Concentration of Avenanthramides: We have successfully produced and sold small batches for inclusion in cream formulations. &nbsp;</li>
<li>JuventeDC Product Line: New website, <a href="https://juventedc.com/en">juventedc.com</a>, was launched on December 19, 2024. &nbsp;</li>
</ul>
Nutraceuticals:
<ul>
<li>Yeast Beta Glucan (YBG) Powder - Immune Booster: Our YBG product has been successfully manufactured as part of our PGX scale up project in Edmonton, Alberta. Our YBG product is being finalized in capsule form with the goal to commercialize it as an immune booster in Q2 2025. &nbsp;</li>
<li>Oat Beta Glucan (OBG) Chewable Bar – Cholesterol Reduction: We have successfully developed a unique, standardized formulation for a healthy confection which includes a high concentration of OBG with daily dosage according to approved claims in 10 developed countries. The substantive claims include reduction of LDL cholesterol, supporting cardiovascular health reduction of Type 2 diabetes risks, source of fiber for the maintenance of general good health and support of a healthy digestive system. COSCIENS' team anticipates the official commercial launch of its chewable bar OBG natural health product in Q1 2025, marking an important chapter in the Company's journey toward promoting wellness while expanding its business model. &nbsp;</li>
</ul>
Macimorelin:
<ul>
<li>On August 27, 2024, the Company announced that the Phase 3 safety and efficacy study AEZS-130-P02 (the "DETECT-trial") evaluating macimorelin for the diagnosis of Childhood Onset Growth Hormone Deficiency ("CGHD") had failed to meet its primary endpoints according to the definitions in the study protocol. Based on the results of the study, we are prioritizing our pipeline moving forward and repositioning the Company as a pure play Life Science's business offering natural-based products. Therefore, while maintaining the current commercial indication for the use of macimorelin for the diagnosis of Adult Growth Hormone Deficiency ("AGHD"), the Company has decided to not make any future investments in macimorelin for the diagnosis of CGHD. Consequently, in order to further ensure the streamlining of operations and reduce costs, the roles of some additional members of management have been terminated, including Dr. Nicola Ammer, Chief Medical Officer, which will be ending on March 31, 2025. &nbsp;</li>
</ul>

CSCI

TSX:CSCI

COSCIENS Biopharma Shifts Focus to Natural-Based Products for Health & Wellness

Barclays analyst David Strauss maintains Textron (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TXT#NYSE">TXT</a>) with a Overweight and lowers the price target from $104 to $95.

Barclays Maintains Overweight on Textron, Lowers Price Target to $95

Ennis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EBF#NYSE">EBF</a>) just disclosed its Q3 earnings on Monday, December 23, 2024 at 06:00 AM.
Here's a brief overview of the earnings report.
<h3>Earnings</h3>
Ennis missed estimated earnings by 0.0%, reporting an EPS of $0.39 versus an estimate of $0.39.
Revenue was down $4.85 million from the same period last year.
<h3>Historical Earnings Summary</h3>
The company missed on EPS by $0.02 in the last quarter, resulting in a 2.0% increase share price change the following day.
Here's a look at Ennis's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.42</td>
<td>0.36</td>
<td>0.39</td>
<td>0.42</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.40</td>
<td>0.41</td>
<td>0.39</td>
<td>0.38</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>104.58M</td>
<td>100.85M</td>
<td>101.40M</td>
<td>102.40M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>99.04M</td>
<td>103.11M</td>
<td>97.43M</td>
<td>104.62M</td>
</tr>
</tbody>
</table>

 Listen to the earnings announcement yourself by <a href="">clicking here</a>. 
To track all earnings releases for Ennis <a href="https://www.benzinga.com/quote/EBF/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings

Ennis: Q3 Earnings Insights

Stifel analyst Benjamin Nolan maintains New Fortress Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) with a Buy and raises the price target from $16 to $17.

Stifel Maintains Buy on New Fortress Energy, Raises Price Target to $17

Chinese company Sophgo whose Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>)-made chip was allegedly found in a Huawei Technologies Co artificial-intelligence processor, faces potential blacklisting from the U.S.
Bitcoin mining equipment supplier Bitmain affiliate Sophgo is the latest Chinese company potentially on the U.S. semiconductor embargo list, citing national security threats, Reuters reports.
In October, tech research firm TechInsights reportedly discovered the Taiwan Semiconductor chip in the Huawei 910B and told the chipmaker, which notified the U.S. Commerce Department.
Also Read: <a target="_blank" href="https://www.benzinga.com/government/regulations/24/12/42621868/nvidia-secures-eu-approval-for-runai-deal-us-probes-china-export-breach" rel="noreferrer noopener">Nvidia Secures EU Approval For Run:ai Deal, US Probes China Export Breach</a>
After determining the chip matched Sophgo&#8217;s design, Taiwan Semiconductor suspended <a target="_blank" href="https://www.benzinga.com/government/24/10/41573440/whats-going-on-with-taiwan-semiconductor-stock-on-monday" rel="noreferrer noopener">shipments to the company</a>.
Sophgo, a supplier to local governments and state-owned firms like China Telecom, denied the charges in October. Huawei also denied the allegations, Reuters report said.
On November 11, the U.S. urged Taiwan Semiconductor to suspend shipments of seven-nanometer or more advanced chips to China. The U.S. sanctions forbid exporters from shipping goods and technology without a license, which will likely be denied.
In December, the <a target="_blank" href="https://www.benzinga.com/government/regulations/24/12/42265847/biden-targets-china-with-new-chip-restrictions-nvidia-slides." rel="noreferrer noopener">U.S. government sanctioned</a> 140 Chinese semiconductor firms, including chip equipment manufacturers such as&nbsp;Naura Technology Group and others, targeting advanced memory chips and chipmaking tools.
The U.S. added telecom equipment maker Huawei to its Entity List in 2019, restricting its access to foreign-made chips since 2020. However, over the past two years, Chinese state-run universities building AI tools and police stations splurged on Sophgo and Bitmain AI chips to upgrade their capabilities.
The U.S. sanctions prompted Huawei to diversify into an AI chip powerhouse. China considers Huawei&#8217;s Ascend 910B the most advanced AI chip in the country. Huawei plans to commercialize its Ascend 910C in early 2025 to rival Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>).
Taiwan Semiconductor stock is trading upwards on Monday. At the end of last week, the Taiwanese contract chipmaker&#8217;s stocks were trading at ~ a 25% premium to those in its domestic market, Bloomberg <a target="_blank" href="https://www.bloomberg.com/news/articles/2024-12-23/us-investors-pay-biggest-premium-for-tsmc-shares-in-two-months?srnd=phx-technology&amp;sref=TBDibEcD" rel="noreferrer noopener">reports</a>, signaling investors&#8217; conviction in the AI frenzy.
This marks a record premium since October 17, beating the quarter&#8217;s daily average of 19%.
Price Action: TSM stock is up 1.75% at $200.67 premarket at last check Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42614272/us-listed-chinese-stocks-react-as-central-bank-keeps-key-rates-steady-amid-yuan-challenges-and-fed-cuts" target="_blank" rel="noreferrer noopener">US-Listed Chinese Stocks Fall As China&#8217;s Central Bank Keeps Key Rates Steady</a></li>
</ul>
Photo via Shutterstock

Government

Regulations

Emerging Markets

Media

Biden Administration Targets Chinese Firm Over Taiwan Semiconductor Chip Found in Huawei Tech

Stifel analyst Stephen Gengaro maintains Schlumberger (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLB#NYSE">SLB</a>) with a Buy and lowers the price target from $60 to $59.

Stifel Maintains Buy on Schlumberger, Lowers Price Target to $59

Fundamentals Vs. Politics: What Could Drive Markets Going Forward?

Back To Business

Why The Election Rally Could Continue

The Enduring Advantage

Tech Concentration: A Global Phenomenon

Getting Active To Identify AI Winners

2025 Outlook: Building The Transformation

How Methodology Affects U.S. Technology Index Performance

Cloud ETFs are poised for growth due to rising AI-driven innovation, increasing public cloud spending, demand for data security, and businesses investing in flexible cloud solutions. Hence, investors could consider top cloud ETFs like the Global X Cloud Computing ETF (CLOU), WisdomTree Cloud Computing Fund (WCLD), and First Trust Cloud Computing ETF (SKYY). Keep reading... As businesses navigate challenges related to data ownership and security, cloud solutions are gaining traction, moving beyond traditional providers. Meanwhile, AI fuels innovation in cloud offerings, driving growth in both public and private cloud services and creating strong investment opportunities in cloud ETFs.
With a heightened focus on AI capabilities and data security, investors should consider top cloud ETFs, such as Global X Cloud Computing ETF Global X Cloud Computing ETF (<a href="https://stocknews.com/stock/CLOU/">CLOU</a>), WisdomTree Cloud Computing Fund (<a href="https://stocknews.com/stock/WCLD/">WCLD</a>), and First Trust Cloud Computing ETF (<a href="https://stocknews.com/stock/SKYY/">SKYY</a>).
Cloud providers are embracing retrieval-augmented generation (RAG) services to improve generative AI accuracy, driving innovation and competitiveness. As businesses invest in cloud technology for flexibility and growth, global public cloud spending is projected to rise 20.4% to <a href="https://www.gartner.com/en/newsroom/press-releases/2024-05-20-gartner-forecasts-worldwide-public-cloud-end-user-spending-to-surpass-675-billion-in-2024#:~:text=Worldwide%20end%2Duser%20spending%20on,(GenAI)%20and%20application%20modernization.">$675.40 billion in 2024</a>, while the overall cloud computing market is projected to reach <a href="https://cisomag.com/cloud-is-booming-and-it-is-going-to-get-better-in-2025-and-beyond/#:~:text=Cloud%20vendors%20will%20be%20working,at%20%24945%20million%20by%202025.">$945 billion by 2025</a>.
Hence, investors are increasingly turning to cloud computing ETFs, which focus on companies powering the digital revolution through infrastructure, software, and platforms. These ETFs present strong growth opportunities, benefiting from the sector's rapid expansion. Given this favorable backdrop, let's evaluate the three <a href="https://stocknews.com/category/technology-equities-etfs/">Technology Equities ETFs</a> picks, starting with number three.
ETF #3: Global X Cloud Computing ETF Global X Cloud Computing ETF (<a href="https://stocknews.com/stock/CLOU/">CLOU</a>)
CLOU is an exchange-traded fund launched and managed by Global X Management Company LLC. It invests in the public equity markets globally. The fund invests in stocks of companies in "SaaS," "PaaS," "IaaS," managed server storage, data center "REITs," and cloud and edge computing infrastructure, focusing on both growth and value stocks across diverse market capitalizations. It seeks to track the performance of the Indxx Global Cloud Computing Index using a full replication technique.
With $381.90 million in assets under management (AUM), CLOU's top holding Snowflake, Inc. (<a href="https://stocknews.com/stock/SNOW/">SNOW</a>) with a 4.81% weighting, followed by Shopify, Inc. (<a href="https://stocknews.com/stock/SHOP/">SHOP</a>), with a 4.79% weighting, and Twilio, Inc. (<a href="https://stocknews.com/stock/TWLO/">TWLO</a>), with 4.63%. It has a total of 38 holdings.
It has an expense ratio of 0.68%, higher than the category average of 0.58%. It currently has a <a href="https://www.investopedia.com/terms/n/nav.asp">NAV</a> of $25.12. CLOU's fund outflows were $13.93 million over the past month.
CLOU has gained 27.2% over the past three months and 32.1% over the past six months to close the last trading session at $25.38.
CLOU's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> reflect this promising outlook. The ETF's overall A rating equates to a Strong Buy in our proprietary rating system. The POWR Ratings are calculated by considering 118 different factors, each weighted to an optimal degree.
CLOU has an A grade for Buy &amp; Hold and Trade and a B for Peer. Of the 119 ETFs in the A-rated <a href="https://stocknews.com/category/technology-equities-etfs/">Technology Equities ETFs</a> group, it is ranked #40. <a href="https://stocknews.com/stock/CLOU/">Click here</a> to access all of CLOU's POWR Ratings.
ETF #2: WisdomTree Cloud Computing Fund (<a href="https://stocknews.com/stock/WCLD/">WCLD</a>)
WCLD is an exchange-traded fund launched by WisdomTree, Inc. The fund is co-managed by Mellon Investments Corporation and WisdomTree Asset Management, Inc. The fund invests in global public equity markets, targeting stocks of companies in the cloud computing sectors. It focuses on both growth and value stocks across various market capitalizations and includes socially conscious companies promoting environmental responsibility. WCLD seeks to track the performance of the BVP Nasdaq Emerging Cloud Index using a representative sampling technique.
With $533.50 million in AUM, the fund has a total of 65 holdings. WCLD's top holding is TWLO with a 2.24% weighting, followed by Asana, Inc. (<a href="https://stocknews.com/stock/ASAN/">ASAN</a>), with a 2.22% weighting, and Atlassian Corp. (<a href="https://stocknews.com/stock/TEAM/">TEAM</a>) with 2.19%.
WCLD has an expense ratio of 0.45%, lower than the category average of 0.58%. It currently has a NAV of $39.92. Its fund inflows came in at $20.36 million over the past month.
WCLD has gained 34.4% over the past six months and 30.3% over the past three months to close the last trading session at $40.64.
WCLD's strong outlook is reflected in its POWR Ratings. The ETF has an overall rating of A, translating to a Strong Buy in our proprietary rating system.
It has an A grade for Buy &amp; Hold and Trade. It is ranked #35 in the same group. To access all the POWR Ratings for WCLD, <a href="https://stocknews.com/stock/WCLD/">click here</a>.
ETF #1: First Trust Cloud Computing ETF (<a href="https://stocknews.com/stock/SKYY/">SKYY</a>)
SKYY is an exchange-traded fund launched and managed by First Trust Advisors LP. The fund invests in public equity markets, targeting companies in information technology, software, IT and internet services, infrastructure, data management, storage, hardware, and platforms for software creation via virtualization or middleware delivered online. It invests in both growth and value stocks across diversified market capitalizations and seeks to track the performance of the ISE CTA Cloud Computing Index using a full replication technique.
With $3.85 billion in AUM, the fund has a total of 64 holdings. SKYY's top holding is AppLovin Corp. (<a href="https://stocknews.com/stock/APP/">APP</a>), with a 5.27% weighting, followed by Amazon.com, Inc. (<a href="https://stocknews.com/stock/AMZN/">AMZN</a>), with a 3.84% weighting, and Arista Networks, Inc. (<a href="https://stocknews.com/stock/ANET/">ANET</a>) with 3.84%.
SKYY has an expense ratio of 0.60%, higher than the category average of 0.58%. It currently has a NAV of $125.38. Its fund outflows came in at $110.84 million over the past month.
SKYY has gained 45% year-to-date and 46.5% over the past year to close the last trading session at $127.16.
SKYY's strong outlook is reflected in its POWR Ratings. The ETF has an overall rating of A, translating to a Strong Buy in our proprietary rating system.
It has an A grade for Buy &amp; Hold and Trade. It is ranked #13 in the Technology Equities ETFs group. To access all the POWR Ratings for SKYY, <a href="https://stocknews.com/stock/SKYY/">click here</a>.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>

<hr />
SKYY shares were trading at $126.25 per share on Tuesday afternoon, down $0.91 (-0.72%). Year-to-date, SKYY has gained 44.01%, versus a 28.06% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Abhishek Bhuyan</h2> <img src='https:/wp-content/uploads/2023/07/ABhuyan.jpg' style="float:left; padding:5px;width:125px;">Abhishek embarked on his professional journey as a financial journalist due to his keen interest in discerning the fundamental factors that influence the future performance of financial instruments.<a href="https://stocknews.com/authors/?author=abhishek-bhuyan">More...</a>The post <a href=https://stocknews.com/news/skyy-wcld-clou-3-cloud-etfs-poised-for-growth-in-2024/>3 Cloud ETFs Poised for Growth in 2024</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

Comments

Global X Cloud Computing ETF

뉴스

에 대한 최신 뉴스 Global X Cloud Computing ETF (NASDAQ:CLOU)

월요일, 12월 23, 2024

뉴스

파트너 / 기고자

벤징가 글로벌